½ÃÀ庸°í¼­
»óǰÄÚµå
1474865

µ¿¹°¿ë Àΰø ¼öÁ¤ ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® ¸®Æ÷Æ® : ¼Ö·ç¼Çº°, µ¿¹° À¯Çüº°, À¯Åë ä³Îº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2024-2030³â)

Veterinary Artificial Insemination Market Size, Share & Trends Analysis Report By Solutions (Equipment & Consumables, Semen, Services), By Animal Type, By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Grand View Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 160 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

µ¿¹°¿ë Àΰø ¼öÁ¤ ½ÃÀåÀÇ ¼ºÀå°ú µ¿Çâ :

Grand View Research, Inc.ÀÇ ÃֽЏ®Æ÷Æ®¿¡ µû¸£¸é ¼¼°èÀÇ µ¿¹°¿ë Àΰø ¼öÁ¤ ½ÃÀåÀº 2030³â±îÁö 112¾ï 5,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, 2024-2030³âÀÇ CAGRÀº 6.34%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù.

½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎÀ¸·Î´Â µ¿¹°¼º ´Ü¹éÁú ¼Òºñ Áõ°¡, °¡Ãà »ý»ê¼º¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, À¯¼º Á¤¾× äÅà µîÀÌ ÀÖÀ¸¸ç, 2023³â 3¿ù È£ÁÖ ÃÖ´ë Àΰø ¹ø½Ä ¾÷üÀÎ Genetics Australia´Â µ¿¹°¿ë Àΰø ¼öÁ¤ ¾÷°èÀÇ ¼±µÎ ±â¾÷ÀÎ URUS¿Í ÇÕº´ÇÑ´Ù°í ¹ßÇ¥Çß½À´Ï´Ù. ÇÕº´ÇÑ´Ù°í ¹ßÇ¥Çß½À´Ï´Ù. À̸¦ ÅëÇØ Genetics Australia´Â È£ÁÖ À¯ÀüÀÚ¸¦ ÆÇ¸ÅÇÒ ¼ö ÀÖ´Â ¼¼°è ½ÃÀå¿¡ Á¢±ÙÇÒ ¼ö ÀÖ°Ô µË´Ï´Ù.

COVID-19´Â ¼ºÀå µÐÈ­, ¿µ¾÷ ¹× ¸¶ÄÉÆÃ È°µ¿ °¨¼Ò, °ø±Þ¸Á Àå¾Ö, Àΰø¼öÁ¤ ¼­ºñ½º Á¦°ø Áö¿¬ µî ¸¹Àº ¹®Á¦¸¦ ¾ß±âÇß½À´Ï´Ù. ÀϺΠÁÖ¿ä ½ÃÀåÀÇ ºÒ±ÔÄ¢ÇÏ°í ºÒÈ®½ÇÇÑ ¼Òºñ ÆÐÅÏÀº »ê¹ßÀûÀÎ ºÀ¼â¿Í ¹°·ù º´¸ñ Çö»óÀ¸·Î ÀÎÇØ ´õ¿í ¾ÇÈ­µÇ¾î ½ÃÀåÀÇ ºÒÈ®½Ç¼ºÀ» ´õ¿í °¡Áß½ÃÄ×½À´Ï´Ù. ¾ÆÇÁ¸®Ä«µÅÁö¿­º´°ú °°Àº ´Ù¸¥ ¿äÀε鵵 ¼ºÀåÀ» µÐÈ­½ÃÄ×½À´Ï´Ù. ¿¹¸¦ µé¾î Áö´©½º´Â ³ëµ¿·Â ºÎÁ·, ¼Ò¸Å ¿Ü½Ä ¼ö¿ä ¹× À°·ù °¡°ø ´É·Â¿¡ ´ëÇÑ ºÎÁ¤ÀûÀÎ ¿µÇâ, Àü¿°º´À¸·Î ÀÎÇÑ ±¹Á¦ ¹°·ù Áö¿¬ µîÀ» º¸°íÇß½À´Ï´Ù. ÀÌ È¸»ç´Â ´çºÐ°£ »ç·á ÅõÀÔ ºñ¿ë, ASF, COVID-19ÀÇ ¿µÇâÀÌ ¼¼°è ¾çµ· »ê¾÷, ƯÈ÷ Áß±¹°ú À¯·´¿¡ °è¼Ó ¾Ð·ÂÀ» °¡ÇÒ °ÍÀ̶ó°í ÁöÀûÇß½À´Ï´Ù. ºÏ¹Ì¿¡¼­´Â 2021³â »ó¹Ý±â¿¡ Àü¿°º´À¸·Î ÀÎÇØ Æ÷Àå °øÀåÀÇ °¡µ¿ÀÌ Áß´ÜµÈ ¹Ù ÀÖ½À´Ï´Ù.

À°·ù ¹× À¯Á¦Ç°¿¡ ´ëÇÑ Áö¼ÓÀûÀÎ ¼ö¿ä Áõ°¡¸¦ ÃæÁ·½Ã۱â À§ÇØ ½ÃÀå °ü°èÀÚµéÀº °íǰÁú °¡ÃàÀ» ¹ø½Ä½ÃŰ°í »ý»êÀ» °­È­Çϱâ À§ÇØ Àΰø¼öÁ¤ ¼Ö·ç¼ÇÀ» È®´ëÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î 2020³â 8¿ù ÄÚÁ¨Æ®´Â AB À¯·´°ú ÇÔ²² ¿µ±¹ÀÇ ¾ç »ý»êÀÚ¸¦ À§ÇÑ »õ·Î¿î À¯¼º Á¤¾× ¼­ºñ½º¸¦ ½ÃÀÛÇßÀ¸¸ç, 2021³â 9¿ù¿¡´Â ´ºÁú·£µå¿¡ ±â¹ÝÀ» µÐ ³ó¾÷ ±â¼ú Çùµ¿Á¶ÇÕÀÎ LIC°¡ Áõ°¡ÇÏ´Â ¼ö¿ä¸¦ ÃæÁ·½Ã۱â À§ÇØ ¿µ±¹¿¡ À¯¼º Á¤¾× ¿¬±¸¼Ò¸¦ °³¼³Çß½À´Ï´Ù. À̸¦ ÅëÇØ Çùµ¿Á¶ÇÕÀº 2021³â 9¿ùºÎÅÍ 12¿ù±îÁö º½Ã¶ ¹ßÁ¤±â¿¡ ¾à 450¸¸ ¸¶¸®ÀÇ ¼Ò¸¦ Àΰø¼öÁ¤ÇÒ ¼ö ÀÖ´Â ´É·ÂÀ» °®Ãß°Ô µÇ¾ú½À´Ï´Ù. ¶óƾ¾Æ¸Þ¸®Ä«¿Í °°Àº °³¹ßµµ»ó±¹ ½ÃÀåµµ µ¿¹°¿ë Àΰø ¼öÁ¤ ½ÃÀåÀÇ ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î ÀÌ Áö¿ªÀÇ ÁÖ¿ä ±¹°¡ Áß ÇϳªÀÎ ºê¶óÁúÀº Áö³­ 10³â°£ AI¸¦ Á¡Á¡ ´õ ¸¹ÀÌ Ã¤ÅÃÇϰí ÀÖ½À´Ï´Ù. ÀÌ ±¹°¡´Â ¶ÇÇÑ ¼öÀͼº°ú ¼º°ø·üÀ» ³ôÀ̱â À§ÇØ Á¤½Ã Àΰø¼öÁ¤(FTAI) ±â¼úÀ» µµÀÔÇϰí ÀÖ½À´Ï´Ù.

µ¿¹°¿ë Àΰø¼öÁ¤ ½ÃÀå º¸°í¼­ - ÇÏÀ̶óÀÌÆ®

  • ¼Ö·ç¼Çº°·Î´Â ¼­ºñ½º ºÎ¹®ÀÌ 2023³â 42.05%ÀÇ ÃÖ´ë ¸ÅÃâ Á¡À¯À²·Î ½ÃÀåÀ» ÁÖµµÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¹Ý¸é, Á¤¾× ºÎ¹®Àº ¿¹Ãø ±â°£ Áß 6.98%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î °¡Àå ºü¸£°Ô ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
  • Àΰø¼öÁ¤(AI)Àº ¹ø½ÄÀ» À§ÇÑ ¾ÈÀüÇϰí ÅëÁ¦µÈ ȯ°æÀ» Á¦°øÇÏ¿© ÀÚ¿¬ ±³¹è Áß ¹ß»ýÇÒ ¼ö ÀÖ´Â ÀçÇØ¿Í ºÎ»óÀÇ °¡´É¼ºÀ» ³·Ãä´Ï´Ù. ¶ÇÇÑ AI´Â ¹ø½ÄÀÚ°¡ ¹ø½Ä °úÁ¤À» ´õ Àß Á¦¾î ÇÒ ¼ö ÀÖµµ·ÏÇÏ¿© ±³¹è°¡ °¡´ÉÇÑ ÃÖ»óÀÇ Á¶°Ç¿¡¼­ ±³¹è°¡ ÀÌ·ç¾îÁö°í »ýÁ¸ °¡´ÉÇÑ Àӽа¡´É¼ºÀ» ³ôÀÔ´Ï´Ù.
  • ÆÇ¸Å ä³Îº°·Î´Â ¹Î°£ ºÎ¹®ÀÌ 2023³â 64.32%ÀÇ ÃÖ´ë ¸ÅÃâ Á¡À¯À²·Î ½ÃÀåÀ» ÁÖµµÇÏ°í ¿¹Ãø ±â°£ Áß °¡Àå ºü¸¥ CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
  • µ¿¹° À¯Çüº°·Î´Â ¼Ò ºÎ¹®ÀÌ 2023³â 40.52%ÀÇ °¡Àå Å« ¸ÅÃâ Á¡À¯À²·Î ½ÃÀåÀ» Â÷ÁöÇß½À´Ï´Ù. µÅÁö ºÎ¹®Àº ¿¹Ãø ±â°£ Áß 6.81%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î °¡Àå ºü¸£°Ô ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
  • ºÏ¹Ì´Â 2023³â 30.28%ÀÇ ¸ÅÃâ Á¡À¯À²·Î ½ÃÀåÀ» Àå¾ÇÇß½À´Ï´Ù. ¶óƾ¾Æ¸Þ¸®Ä«Àº ¿¹Ãø ±â°£ Áß ¿¬Æò±Õ 7.07%ÀÇ °¡Àå ºü¸¥ ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
  • ¼¼°è Àα¸°¡ Áö¼ÓÀûÀ¸·Î Áõ°¡ÇÔ¿¡ µû¶ó À°·ù, ¿ìÀ¯, °è¶õ°ú °°Àº µ¿¹°¼º ´Ü¹éÁú¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ¿¡ µû¶ó °¡Ãà »ý»êÀ» ÃÖÀûÈ­Çϱâ À§ÇÑ È¿À²ÀûÀÎ ¹ø½Ä ¹æ¹ýÀÇ Çʿ伺ÀÌ Áõ°¡Çϰí ÀÖÀ¸¸ç, ¿©±â¿¡´Â À¯ÀüÇÐ ¹× ¹ø½Ä È¿À²À» °³¼±Çϱâ À§ÇÑ Àΰø¼öÁ¤ÀÇ È°¿ëÀÌ Æ÷ÇԵ˴ϴÙ.

¸ñÂ÷

Á¦1Àå µ¿¹°¿ë Àΰø ¼öÁ¤ ½ÃÀå : Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå µ¿¹°¿ë Àΰø ¼öÁ¤ ½ÃÀå : ÁÖ¿ä ¿ä¾à

  • ½ÃÀå Àü¸Á
  • ºÎ¹® Àü¸Á
  • °æÀï ÀλçÀÌÆ®

Á¦3Àå µ¿¹°¿ë Àΰø ¼öÁ¤ ½ÃÀå : ¾÷°è Àü¸Á

  • ½ÃÀå °èÅë Àü¸Á
  • ½ÃÀå ¿ªÇÐ
  • µ¿¹°¿ë Àΰø ¼öÁ¤ ½ÃÀå ºÐ¼® Åø

Á¦4Àå µ¿¹°¿ë Àΰø ¼öÁ¤ ½ÃÀå : ¼Ö·ç¼Ç ÃßÁ¤¡¤µ¿Ç⠺м®

  • ºÎ¹® ´ë½Ãº¸µå
  • ¼¼°èÀÇ µ¿¹°¿ë Àΰø ¼öÁ¤ ½ÃÀå : ¼Ö·ç¼ÇÀÇ µ¿Ç⠺м®
  • ¼¼°èÀÇ µ¿¹°¿ë Àΰø ¼öÁ¤ ½ÃÀå ±Ô¸ð¡¤µ¿Ç⠺м®, ¼Ö·ç¼Çº°, 2018-2030³â
  • Àåºñ¿Í ¼Ò¸ðǰ
  • Á¤¾×
  • ¼­ºñ½º

Á¦5Àå µ¿¹°¿ë Àΰø ¼öÁ¤ ½ÃÀå : µ¿¹° À¯Çü ÃßÁ¤¡¤µ¿Ç⠺м®

  • ºÎ¹® ´ë½Ãº¸µå
  • ¼¼°èÀÇ µ¿¹°¿ë Àΰø ¼öÁ¤ ½ÃÀå : µ¿¹° À¯ÇüÀÇ µ¿Ç⠺м®
  • ¼¼°èÀÇ µ¿¹°¿ë Àΰø ¼öÁ¤ ½ÃÀå ±Ô¸ð¿Í µ¿Ç⠺м®, µ¿¹° À¯Çüº°, 2018-2030³â

Á¦6Àå µ¿¹°¿ë Àΰø ¼öÁ¤ ½ÃÀå : À¯Åë ä³Î ÃßÁ¤¡¤µ¿Ç⠺м®

  • ºÎ¹® ´ë½Ãº¸µå
  • ¼¼°èÀÇ µ¿¹°¿ë Àΰø ¼öÁ¤ ½ÃÀå : À¯Åë ä³ÎÀÇ µ¿Ç⠺м®
  • ¼¼°èÀÇ µ¿¹°¿ë Àΰø ¼öÁ¤ ½ÃÀå ±Ô¸ð¿Í µ¿Ç⠺м®, À¯Åë ä³Îº°, 2018-2030³â
  • ¹Î°£
  • °øÀû

Á¦7Àå µ¿¹°¿ë Àΰø ¼öÁ¤ ½ÃÀå : Áö¿ª ÃßÁ¤¡¤µ¿Ç⠺м®

  • Áö¿ªÀÇ ´ë½Ãº¸µå
  • µ¿¹°¿ë Àΰø ¼öÁ¤ ½ÃÀå Á¡À¯À², Áö¿ªº°, 2023³â¡¤2030³â
  • Áö¿ªÀÇ Àü¸Á
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • ¿µ±¹
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ³ë¸£¿þÀÌ
    • µ§¸¶Å©
    • ½º¿þµ§
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ÀϺ»
    • Áß±¹
    • Àεµ
    • È£ÁÖ
    • Çѱ¹
    • ű¹
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ¾Æ¸£ÇîÆ¼³ª
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®

Á¦8Àå °æÀï ±¸µµ

  • ½ÃÀå Âü¿© ±â¾÷ ºÐ·ù
  • ±â¾÷ ½ÃÀå ÇöȲ ºÐ¼®/heap ¸Ê ºÐ¼®
  • ±â¾÷ °³¿ä
    • Genus
    • URUS Group LP
    • CRV
    • Semex
    • IMV Technologies
    • Select Sires Inc.
    • Swine Genetics International
    • Shipley Swine Genetics
    • Stallion AI Services Ltd
    • STgenetics
  • Àü·« ¸ÅÇÎ
KSA 24.05.20

Veterinary Artificial Insemination Market Growth & Trends:

The global veterinary artificial insemination market is anticipated to reach USD 11.25 billion by 2030 and is projected to grow at a CAGR of 6.34% from 2024 to 2030, according to a new report by Grand View Research, Inc. The key factors driving the market growth include increasing consumption of animal protein, growing demand for livestock productivity, and adoption of sexed semen. In March 2023, Genetics Australia - the country's largest artificial breeding supplier announced that it would merge with URUS - a leading player in the veterinary artificial insemination industry. This would provide Genetics Australia access to global markets in marketing Australian genetics.

The COVID-19 pandemic resulted in many challenges including dampened growth, decreased sales and marketing activities, supply chain hurdles, and delays in the delivery of AI services. The erratic and uncertain consumption patterns in several key markets exacerbated by sporadic lockdowns and logistical bottlenecks further increased the uncertainty in the market. The growth was also dampened by other factors such as the African Swine-Fever. Genus, for instance, reported labor shortages, adverse impact on retail food service demand and meat packing capacity, and international logistics delays due to the pandemic. The company indicated that in the near-term, feed input costs, ASF, and COVID-19 implications would continue to exert pressure on the global porcine industry, particularly in China and Europe. In North America, the pandemic led to packing plant slowdowns during H1 of 2021.

To fulfill the continuously increasing demand for meat and dairy products, market players are expanding artificial insemination solutions to breed high-quality livestock and enhance production. For example, in August 2020, Cogent with AB Europe launched a novel sexed semen service for U.K. sheep producers. In September 2021, LIC- an agritech co-operative based in New Zealand launched a sexed semen lab in the country to meet the growing demand. This boosted the cooperative's capabilities to artificially inseminate about 4.5 million cattle between the Spring mating season of September to December 2021. Developing regions such as Latin America are also contributing to the market growth for veterinary artificial insemination. For instance, Brazil, one of the major countries in the region has been adopting AI increasingly for the past decade. The country has also deployed Fixed-Time Artificial Insemination (FTAI) techniques to increase profitability and success rate.

Veterinary Artificial Insemination Market Report Highlights:

  • Based on solutions, the services segment led the market with the largest revenue share of 42.05% in 2023. The semen segment on the other hand is anticipated to grow at the fastest CAGR of 6.98% over the forecast period
  • Artificial insemination (AI) offers a safe and regulated environment for breeding, lowering the possibility of mishaps or injuries that could happen during natural mating. Furthermore, AI gives breeders more control over the breeding process, ensuring that mating takes place under the best possible circumstances, and raises the likelihood of viable pregnancies
  • Based on distribution channel, the private segment led the market with the largest revenue share of 64.32% in 2023 and is also projected to grow at the fastest CAGR over the forecast period
  • Based on animal type, the bovine segment held the market with the largest revenue share of 40.52% in 2023. The swine segment is estimated to grow at the fastest CAGR of 6.81% during the forecast period
  • North America dominated the market with the revenue share of 30.28% in 2023. Latin America region is estimated to grow at the fastest CAGR of 7.07% over the forecast period
  • As the global population continues to grow, there is an increasing demand for animal protein, including meat, milk, and eggs. This drives the need for efficient breeding practices to optimize livestock production, which includes the use of artificial insemination to improve genetics and reproductive efficiency

Table of Contents

Chapter 1. Veterinary Artificial Insemination Market: Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Sources
    • 1.3.4. Primary Research
  • 1.4. Information/Data Analysis
  • 1.5. Market Formulation & Visualization
  • 1.6. Data Validation & Publishing
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis
    • 1.7.2. Global Market: CAGR Calculation
  • 1.8. List of Secondary Sources

Chapter 2. Veterinary Artificial Insemination Market: Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Veterinary Artificial Insemination Market: Industry Outlook

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing demand for meat, dairy, and dairy products
      • 3.2.1.2. Increasing need for sustainable food production
      • 3.2.1.3. Advancements in animal reproduction technology
      • 3.2.1.4. Supportive Initiatives
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Lack of awareness
      • 3.2.2.2. Limited access to supplies & skilled labor in certain countries
    • 3.2.3. Market Opportunity Analysis
    • 3.2.4. Market Challenge Analysis
  • 3.3. Veterinary Artificial Insemination Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitution
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political & Legal landscape
      • 3.3.2.2. Economic and Social landscape
      • 3.3.2.3. Technological & Environmental landscape
    • 3.3.3. Pricing Analysis
    • 3.3.4. Regulatory Landscape
    • 3.3.5. Estimated Animal Population, by key species & key countries, 2023
    • 3.3.6. COVID-19 Impact Analysis

Chapter 4. Veterinary Artificial Insemination Market: Solutions Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Veterinary Artificial Insemination Market: Solutions Movement Analysis
  • 4.3. Global Veterinary Artificial Insemination Market Size & Trend Analysis, by Solutions, 2018 to 2030 (USD Million)
  • 4.4. Equipment & Consumables
    • 4.4.1. Equipment & Consumables Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Semen
    • 4.5.1. Normal
    • 4.5.2. Normal Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.3. Sexed
    • 4.5.4. Sexed Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Services
    • 4.6.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Veterinary Artificial Insemination Market: Animal Type Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Veterinary Artificial Insemination Market: Animal Type Movement Analysis
  • 5.3. Global Veterinary Artificial Insemination Market Size & Trend Analysis, by Animal Type, 2018 to 2030 (USD Million)
    • 5.3.1. Bovine
      • 5.3.1.1. Bovine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.2. Swine
      • 5.3.2.1. Swine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.3. Ovine & Caprine
      • 5.3.3.1. Ovine & Caprine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.4. Equine
      • 5.3.4.1. Equine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.5. Other Animals
      • 5.3.5.1. Other Animals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Veterinary Artificial Insemination Market: Distribution Channel Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Veterinary Artificial Insemination Market: Distribution Channel Movement Analysis
  • 6.3. Global Veterinary Artificial Insemination Market Size & Trend Analysis, by Distribution Channel, 2018 to 2030 (USD Million)
  • 6.4. Private
    • 6.4.1. Private Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Public
    • 6.5.1. Public Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Veterinary Artificial Insemination Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Dashboard
  • 7.2. Veterinary Artificial Insemination Market Share, By Region, 2023 & 2030 (USD Million)
  • 7.3. Regional Outlook
  • 7.4. North America
    • 7.4.1. North America Veterinary Artificial Insemination Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. U.S. Veterinary Artificial Insemination Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Canada Veterinary Artificial Insemination Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Europe Veterinary Artificial Insemination Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. UK Veterinary Artificial Insemination Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Germany Veterinary Artificial Insemination Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. France Veterinary Artificial Insemination Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Italy Veterinary Artificial Insemination Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Spain Veterinary Artificial Insemination Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.7. Norway
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Norway Veterinary Artificial Insemination Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.8. Denmark
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Denmark Veterinary Artificial Insemination Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.9. Sweden
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Sweden Veterinary Artificial Insemination Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Veterinary Artificial Insemination Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Japan Veterinary Artificial Insemination Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. China Veterinary Artificial Insemination Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. India Veterinary Artificial Insemination Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. Australia
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Australia Veterinary Artificial Insemination Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.6. South Korea
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. South Korea Veterinary Artificial Insemination Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Thailand Veterinary Artificial Insemination Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America Veterinary Artificial Insemination Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Brazil Veterinary Artificial Insemination Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.7.3. Mexico
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Mexico Veterinary Artificial Insemination Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.7.4. Argentina
      • 7.7.4.1. Key Country Dynamics
      • 7.7.4.2. Argentina Veterinary Artificial Insemination Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.8. Middle East & Africa
    • 7.8.1. Middle East & Africa Veterinary Artificial Insemination Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. South Africa Veterinary Artificial Insemination Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Saudi Arabia Veterinary Artificial Insemination Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. UAE Veterinary Artificial Insemination Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
  • 8.2. Company Market Position Analysis/ Heap Map Analysis
  • 8.3. Company Profiles
    • 8.3.1. Genus
      • 8.3.1.1. Participant's Overview
      • 8.3.1.2. Financial Performance
      • 8.3.1.3. Product Benchmarking
      • 8.3.1.4. Strategic Initiatives
    • 8.3.2. URUS Group LP
      • 8.3.2.1. Participant's Overview
      • 8.3.2.2. Financial Performance
      • 8.3.2.3. Product Benchmarking
      • 8.3.2.4. Strategic Initiatives
    • 8.3.3. CRV
      • 8.3.3.1. Participant's Overview
      • 8.3.3.2. Financial Performance
      • 8.3.3.3. Product Benchmarking
      • 8.3.3.4. Strategic Initiatives
    • 8.3.4. Semex
      • 8.3.4.1. Participant's Overview
      • 8.3.4.2. Financial Performance
      • 8.3.4.3. Product Benchmarking
      • 8.3.4.4. Strategic Initiatives
    • 8.3.5. IMV Technologies
      • 8.3.5.1. Participant's Overview
      • 8.3.5.2. Financial Performance
      • 8.3.5.3. Product Benchmarking
      • 8.3.5.4. Strategic Initiatives
    • 8.3.6. Select Sires Inc.
      • 8.3.6.1. Participant's Overview
      • 8.3.6.2. Financial Performance
      • 8.3.6.3. Product Benchmarking
      • 8.3.6.4. Strategic Initiatives
    • 8.3.7. Swine Genetics International
      • 8.3.7.1. Participant's Overview
      • 8.3.7.2. Financial Performance
      • 8.3.7.3. Product Benchmarking
      • 8.3.7.4. Strategic Initiatives
    • 8.3.8. Shipley Swine Genetics
      • 8.3.8.1. Participant's Overview
      • 8.3.8.2. Financial Performance
      • 8.3.8.3. Product Benchmarking
      • 8.3.8.4. Strategic Initiatives
    • 8.3.9. Stallion AI Services Ltd
      • 8.3.9.1. Participant's Overview
      • 8.3.9.2. Financial Performance
      • 8.3.9.3. Product Benchmarking
      • 8.3.9.4. Strategic Initiatives
    • 8.3.10. STgenetics
      • 8.3.10.1. Participant's Overview
      • 8.3.10.2. Financial Performance
      • 8.3.10.3. Product Benchmarking
      • 8.3.10.4. Strategic Initiatives
  • 8.4. Strategy Mapping
    • 8.4.1. Mergers & Acquisitions
    • 8.4.2. Partnerships & Collaborations
    • 8.4.3. Others
  • 8.5. List of Other Key Manufacturers
  • 8.6. List of Distributors by Region
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦